TRENDING Medical education topic: Schizophrenia

What is the problem? 
Schizophrenia affects approximately 24 million people worldwide and is among the most disabling and economically catastrophic medical disorders. Slightly more men are diagnosed with schizophrenia than women, and women tend to be diagnosed later in life than men. Schizophrenia is associated with substantial morbidity and mortality as well as personal and societal costs. Antipsychotic medications, which oftentimes represent an essential therapeutic modality, have many side effects, and therapy must be closely monitored for compliance and adverse reactions. The healthcare professional holds a unique position in the effort to improve adherence to therapy, as different patient needs require different approaches.

Proposed Learning Objectives:
At the conclusion of this activity, the learners will be able to:

• Describe the pathophysiology of schizophrenia and the role the neurotransmitter receptors play in it
• Describe the benefits and risks of pharmacotherapy for schizophrenia
• Formulate a treatment plan for a variety of patients with schizophrenia, including those exhibiting only negative symptoms
• Recommend therapy changes in patients who are unable to tolerate a prescribed treatment
• Identify barriers to care in patients with schizophrenia and develop strategies to abate them

If your medical staff needs an update on schizophrenia, consider contacting our office to book a speaker at 877-505-4777 or info@speakersnetwork.com.

How do we know this is a problem?
https://www.nimh.nih.gov/health/statistics/schizophrenia
https://www.who.int/news-room/fact-sheets/detail/schizophrenia